1. Chand N, Sanyai A. Sepsis – induced cholestasis. Hepatology 2007; 1: 230-241.
2.
Hamilton JR, Sass-Kortsak A. Jaundice associated with severe bacterial infection in young infants. J Pediatr 1963; 63: 121-132.
3.
Kosters A, Karpen S. The role of inflammation in cholestasis – clinical and basic aspects. Semin Liver Dis 2010; 30: 186-194.
4.
Hebanowska A. Bile acid biosynthesis and its regulation. Postepy Hig Med Dosw 2010; 64: 544-554.
5.
Kubitz R, Dröge C, Stind J, et al. The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol 2012; 36: 536-553.
6.
Soroka CJ, Boyer L. Biosynthesis and trafficking of the bile salt export pump, BSEP: Therapeutic implications of BSEP mutations. Mol Aspects Med 2014; 37: 3-14.
7.
Chen Y, Song X, Valanejad L, et al. Bile salt export pomp is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Hepatology 2013; 57: 1530-1541.
8.
Byrne J, Strautnieks S, Ihrke G, et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 2009; 49: 553-567.
9.
Stieger B. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis. Drug Metab Rev 2010; 42: 437-445.
10.
Kim SR, Saito Y, Itoda M, et al. Genetic variations of the ABC transporter gene ABCB11 encoding the human bile salt export pump (BSEP) in a Japanese population. Drug Metab Pharmacokinet 2009; 24: 277-281.
11.
Meier Y, Zodan T, Lang C, et al. Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump. World J Gastroenterol 2008; 14: 38-45.
12.
Lei JH, Yang X, Xiao XQ, et al. A preliminary investigation on single nucleotide polymorphism rs2287622 of bile salt export pump gene in patients with chronic hepatitis C virus infection in Hunan, China. BMC Gastroenterology 2017; 17: 42.
13.
Lang C, Meier Y, Stieger B, et al. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet
14.
Genomics 2007; 17: 47-60.
15.
Habior A. Kwas ursodeoksycholowy w cholestatycznych chorobach wątroby – w jakich sytuacjach jest skuteczny? Gastroenterologia Kliniczna. Postępy i Standardy 2011; 3: 79-87.
16.
Perez MJ, Briz O. Bile-acid-induced cell injury and protection. World J Gastroenterol 2009; 15: 1677-1689.
17.
Strautnieks S, Bull L, Knisely A, et al. A gene encoding a liverspecific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Gene 1998; 20: 233-238.
18.
Piątek K, Kurzawińska G, Magiełda J, et al. The role of ABC transporters’ gene polymorphism in the etiology of intrahepatic cholestasis of pregnancy. Ginekol Pol 2018; 89: 393-397.
19.
Iwata R, Baur K, Stieger B, et al. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci 2011; 120: 287-296.
20.
Ulzurrun E, Stephens C, Crespo E, et al. Role of chemical structures and the 1331T>C bile salt export pump polymorphism in idiosyncratic drug-induced liver injury. Liver Int 2013; 33: 1378-1385.
21.
Chen R, Wang J, Tang S, et al. Role of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort. Sci Rep 2016; 13: 27750.
22.
Iwata R, Stieger B, Mertens C, et al. The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C. J Viral Hepat 2011; 18: 768-778.
23.
Rawa-Gołębiewska A. Kwas ursodeoksycholowy w leczeniu chorób wątroby. Gastroenterol Klin 2016; 8: 131-141.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.